CDAI LDA (score ≤10), n (%)
| | |
Week 2
|
9 (9.1)
|
13 (12.3)
|
Week 8
|
16 (15.4)
|
31 (29.2)
|
Week 12
|
22 (21.2)
|
27 (25.5)
|
Week 24
|
43 (41.3)
|
49 (46.2)
|
CDAI remission (score ≤2.8), n (%)
| | |
Week 2
|
1 (1.0)
|
2 (1.9)
|
Week 8
|
0 (0.0)
|
3 (2.8)
|
Week 12
|
1 (1.0)
|
4 (3.8)
|
Week 24
|
4 (3.8)
|
9 (8.5)
|
SDAI LDA (score ≤11), n (%)
| | |
Week 2
|
8 (8.2)
|
13 (12.4)
|
Week 8
|
15 (14.4)
|
32 (30.2)
|
Week 12
|
22 (21.2)
|
25 (23.6)
|
Week 24
|
41 (39.4)
|
48 (45.3)
|
SDAI remission (score ≤3.3), n (%)
| | |
Week 2
|
1 (1.0)
|
1 (1.0)
|
Week 8
|
0 (0.0)
|
6 (5.7)
|
Week 12
|
2 (1.9)
|
6 (5.7)
|
Week 24
|
7 (6.7)
|
11 (10.4)
|
ACR20 response, n (%)
| | |
Week 2
|
15 (14.9)
|
30 (28.6)
|
Week 8
|
24 (23.1)
|
53 (50.0)
|
Week 12
|
30 (28.8)
|
43 (40.6)
|
Week 24
|
48 (46.2)
|
53 (50.0)
|
ACR50 response, n (%)
| | |
Week 2
|
3 (3.0)
|
6 (5.7)
|
Week 8
|
5 (4.8)
|
21 (19.8)
|
Week 12
|
13 (12.5)
|
22 (20.8)
|
Week 24
|
30 (28.8)
|
35 (33.0)
|
ACR70 response, n (%)
| | |
Week 2
|
0 (0.0)
|
2 (1.9)
|
Week 8
|
0 (0.0)
|
6 (5.7)
|
Week 12
|
1 (1.0)
|
6 (5.7)
|
Week 24
|
13 (12.5)
|
17 (16.0)
|
Change from baseline in HAQ-DI, mean score change (SD)
| | |
Week 2
|
−0.09 (0.39)
|
−0.27 (0.43)
|
Week 8
|
−0.21 (0.42)
|
−0.37 (0.47)
|
Week 12
|
−0.20 (0.43)
|
−0.39 (0.54)
|
Week 24
|
−0.45 (0.52)
|
−0.48 (0.58)
|